A recent cohort study including 60 patients with resistant schizophrenia showed that patients receiving ECT (n = 45) had increased BDNF levels after treatment compared with patients receiving conventional pharmacological treatment (usual treatment with antipsychotics) (n = 15), with a statistically significant difference compared with their baseline BDNF level. The gene discussed is BDNF; the disease is schizophrenia.